Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Rivalyn
    Member
    • Apr 2014
    • 14

    #1

    Chipseq and statistical models

    I was wondering a bit about the statistical models used by peak-calling software and how they compare to the models normally employed by packages designed for RNAseq. It's my understanding that most RNAseq tools for differential expression analysis. The way I understand a negative binomial distribution is that it's a lot like a Poisson distribution, except that a negative binomial distribution takes into account the fact that the mean/variance won't be equal across biological replicates.

    From what I've read, some Chipseq tools use the negative binomial distribution, while others use the Hidden Markov Model (HMM). I read the wikipedia entry on HMM and found it... less than clear. The way I understand it, a Markov model refers to a series of discrete "states", where each state depends upon the previous state in a non-deterministic way. So, for example, a tree might be classified as "small", "medium" or "large". That tree has to go through the "medium" state before it can reach the "large" state, but just because a tree is "medium" doesn't mean it will ever become "large". The size of the tree is related to how rainy it was on a previous year, so if it was exceptionally rainy, there might be a 70% chance that the tree you observe will be large. When refering to a Hidden Markov Model, you refer to a Markov chain in which some of the states are hidden, or unobserved. So to use the tree example, if you didn't have the weather data for the previous year, you'd have to infer how rainy it was based upon how many "large" trees you observe.

    Assuming that understanding isn't completely wrong, I don't really see how it applies to Chipseq. Can someone explain to me why this model is used in Chipseq analysis, and why some tools use negative binomial distribution instead?
    Last edited by Rivalyn; 05-27-2014, 05:50 AM.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
17 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
35 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...